Home/Filings/4/0001479290-19-000113
4//SEC Filing

Joshi Abhay 4

Accession 0001479290-19-000113

CIK 0001479290other

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 7:56 PM ET

Size

4.9 KB

Accession

0001479290-19-000113

Insider Transaction Report

Form 4
Period: 2019-12-14
Joshi Abhay
Chief Operating Officer
Transactions
  • Tax Payment

    Common Stock

    2019-12-14$15.99/sh2,971$47,50685,952 total
Footnotes (1)
  • [F1]Represents the number of shares withheld by and surrendered to the Issuer on December 14, 2019, to satisfy tax withholding obligations that arose in connection with the vesting of a Restricted Stock award ("RSA") for 8,593 shares. The RSA vests in four equal annual installments from December 14, 2015, subject to Dr. Joshi's Continuous Service (as defined in the Issuer's 2014 Inducement Plan) on each vesting date.

Issuer

Revance Therapeutics, Inc.

CIK 0001479290

Entity typeother

Related Parties

1
  • filerCIK 0001359089

Filing Metadata

Form type
4
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 7:56 PM ET
Size
4.9 KB